Evaluating Multiple Sclerosis Patients ShOWing A GEnomic Signature of Therapy Response
NCT03316404 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1168
Last updated 2024-08-06
Summary
To develop a test to characterize and monitor Multiple Sclerosis (MS) disease status and therapy response from a participant's home by analyzing the gene expression from participant self-collected blood samples using a novel fingerstick collection kit.
Conditions
Sponsors & Collaborators
-
DxTerity Diagnostics
lead INDUSTRY
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2017-11-07
- Primary Completion
- 2020-02-24
- Completion
- 2020-02-25
Countries
- United States
Study Locations
More Related Trials
-
A Study of MSDx Complex 1 as a Marker for Therapy Response in Multiple Sclerosis
NCT01541618 ·Status: COMPLETED
-
Analyze the Myelin-TRAP as Diagnostic Tool in Multiple Sclerosis
NCT01723631 ·Status: TERMINATED ·Phase: NA
-
A Cross-Sectional Study of MSDx Complex 1 as a Marker for Active Disease in Multiple Sclerosis
NCT01539395 ·Status: WITHDRAWN
-
Multiple Sclerosis Prediction and Monitoring of Progression Study
NCT05685784 ·Status: RECRUITING ·Phase: NA
-
Coagulation/Complement Activation and Cerebral Hypoperfusion in Relapsing-remitting Multiple Sclerosis
NCT04380220 ·Status: UNKNOWN
-
Relating Genetic and Environmental Risk Scores to Multiple Sclerosis Susceptibility
NCT01617395 ·Status: COMPLETED
-
Gene Expression in MS Patients Before and During Treatment With Interferon-beta
NCT00202384 ·Status: TERMINATED
-
Validation of a Laboratory Test Measuring Natalizumab (Tysabri®) Serum Levels in MS
NCT02965170 ·Status: COMPLETED
-
A Study to Assess the Effects of MK0812 on Disease Activity in Patients With Relapsing-Remitting Multiple Sclerosis as Measured by Magnetic Resonance Imaging (MRI)(0812-003)(COMPLETED)
NCT00239655 ·Status: TERMINATED ·Phase: PHASE2
-
Efficacy and Safety of MBP8298 in Subjects With Secondary Progressive Multiple Sclerosis
NCT00468611 ·Status: TERMINATED ·Phase: PHASE3
-
MS Mosaic: A Longitudinal Research Study on Multiple Sclerosis
NCT02845635 ·Status: COMPLETED
-
Genes and Environment in Multiple Sclerosis
NCT01353547 ·Status: RECRUITING
-
Cellular microRNA Signatures in Multiple Sclerosis
NCT05290688 ·Status: UNKNOWN ·Phase: NA
-
Long-term Effect of Fingolimod on Circulating Immunocompetent Mononuclear Cells in Patients With Multiple Sclerosis
NCT01755871 ·Status: TERMINATED ·Phase: PHASE4
-
Serum Neurofilament Light in Multiple Sclerosis
NCT06282081 ·Status: ACTIVE_NOT_RECRUITING
-
Gene Expression Profiles in Multiple Sclerosis (MS)
NCT00704834 ·Status: COMPLETED
-
Role of Microglia in the Pathogenesis of Progressive Multiple Sclerosis
NCT03134716 ·Status: ACTIVE_NOT_RECRUITING
-
Mechanisms of Disease Severity in Multiple Sclerosis: an Integrative Multimodal Study
NCT03369106 ·Status: ACTIVE_NOT_RECRUITING
-
Tysabri Effects on Cognition and Neurodegeneration in Multiple Sclerosis
NCT01071512 ·Status: COMPLETED ·Phase: NA
-
Advanced MRI Sequences in Multiple Sclerosis and Its Mimics
NCT03608605 ·Status: UNKNOWN
-
ATX-MS-1467 in Multiple Sclerosis
NCT01973491 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate the Efficacy and Safety of Fenebrutinib Compared With Teriflunomide in Relapsing Multiple Sclerosis (RMS)
NCT04586010 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Phase IIIB-IV Long-Term Follow-up Study for Patients Who Participated in CAMMS03409
NCT02255656 ·Status: COMPLETED ·Phase: PHASE4
-
Polymorphisms of Interleukins, Glypican, and Human Leukocyte Antigen Genes and Treatment Response in Multiple Sclerosis.
NCT02769767 ·Status: UNKNOWN
-
Evaluating Intervention Responsiveness in People With Multiple Sclerosis
NCT01632293 ·Status: COMPLETED ·Phase: NA